Role of Clinical Pharmacists in Epilepsy Management
NCT04967326 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 141
Last updated 2021-08-02
Summary
Clinical pharmacists have an important role in inter-professional healthcare collaboration for epilepsy management. However, the pharmacy practices of managing epilepsy are still limited in Vietnam, deterring pharmacists from routine adjustments of antiepileptic drugs, which could decrease the patients' quality of life. This study aimed to assess the effectiveness of pharmacist interventions in epilepsy treatment at a Vietnamese general hospital.
Conditions
Interventions
- DRUG
-
Optimizing therapy with antiepileptic drugs (carbamazepine, phenytoin, valproic acid)
Sponsors & Collaborators
-
Gia Dinh People Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-01
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
More Related Trials
-
Exploration of Genotype Based Personalized Prescription of Valproate Sodium in Anti-epileptic Treatment
NCT01172626 ·Status: UNKNOWN
-
Valproic Acid Use in Patients With Neurological Disorders
NCT05830981 ·Status: COMPLETED ·Phase: NA
-
The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
NCT05697614 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy
NCT01689649 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy
NCT05637086 ·Status: RECRUITING ·Phase: PHASE2
-
Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus
NCT03025906 ·Status: UNKNOWN ·Phase: PHASE2
-
Physiologic Effects of Topiramate on Cognition
NCT02884050 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs
NCT01527006 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Verapamil in Refractory Epilepsy
NCT01126307 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy
NCT01932502 ·Status: UNKNOWN ·Phase: PHASE4
-
Medication Adherence in Individuals With Epilepsy
NCT01566500 ·Status: COMPLETED
-
Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate
NCT05181007 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy
NCT05748236 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy
NCT02736162 ·Status: COMPLETED
-
Study of Excretion Balance and Pharmacokinetics of [14C]-Sodium Valproate (3.7 MBq) in Healthy Postmenopausal or Permanently Sterile Female Subjects
NCT03681158 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacogenetic Study for Topiramate-Induced Cognitive Dysfunction
NCT00731900 ·Status: UNKNOWN
-
Study of Phenobarbital Inhibition of Catamenial Epilepsy
NCT00530413 ·Status: WITHDRAWN ·Phase: NA
-
Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)
NCT03689114 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Anti-epileptic Drugs in Obese Children
NCT02993861 ·Status: COMPLETED
-
Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
NCT04903314 ·Status: COMPLETED ·Phase: PHASE1
-
A Study on the Effects of Valproate on the Pharmacokinetics of RO4917838 in Healthy Volunteers
NCT01495104 ·Status: COMPLETED ·Phase: PHASE1
-
Study The Knowledge and Attitude Towards Epilepsy Among Relatives of People With Epilepsy and Their Impact on The Patient's Quality of Life
NCT05671575 ·Status: UNKNOWN
-
A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093
NCT02171195 ·Status: COMPLETED ·Phase: PHASE1
-
Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.
NCT02283827 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy
NCT00986310 ·Status: COMPLETED ·Phase: NA